ArticleMolecular and cellular biochemistry2025

Elexacaftor/tezacaftor/ivacaftor (ETI) therapy modifies the expression of interferon beta and inflammatory genes in the airways of adult patients with cystic fibrosis: a pilot study.

Camilla Bitossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.